Zimmer up for sale within 12 months, says Bristol-Myers
This article was originally published in Clinica
Executive Summary
The Zimmer orthopaedics business of Bristol-Myers will be sold, spun off or possibly swapped out of the Bristol-Myers portfolio within a year, according to the company in a special announcement to analysts last Thursday.